Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
J Biol Chem ; 288(47): 33500-33508, 2013 Nov 22.
Article in English | MEDLINE | ID: mdl-24108125

ABSTRACT

Genomic instability and a predisposition to cancer are hallmarks of Bloom syndrome, an autosomal recessive disease arising from mutations in the BLM gene. BLM is a RecQ helicase component of the BLM-Topo III α-RMI1-RMI2 (BTR) complex, which maintains chromosome stability at the spindle assembly checkpoint (SAC). Other members of the BTR complex include Topo IIIa, RMI1, and RMI2. All members of the BTR complex are essential for maintaining the stable genome. Interestingly, the BTR complex is posttranslationally modified upon SAC activation during mitosis, but its significance remains unknown. In this study, we show that two proteins that interact with BLM, RMI1 and RMI2, are phosphorylated upon SAC activation, and, like BLM, RMI1, and RMI2, are phosphorylated in an MPS1-dependent manner. An S112A mutant of RMI2 localized normally in cells and was found in SAC-induced coimmunoprecipitations of the BTR complex. However, in RMI2-depleted cells, an S112A mutant disrupted the mitotic arrest upon SAC activation. The failure of cells to maintain mitotic arrest, due to lack of phosphorylation at Ser-112, results in high genomic instability characterized by micronuclei, multiple nuclei, and a wide distribution of aberrantly segregating chromosomes. We found that the S112A mutant of RMI2 showed defects in redistribution between the nucleoplasm and nuclear matrix. The phosphorylation at Ser-112 of RMI2 is independent of BLM and is not required for the stability of the BTR complex, BLM focus formation, and chromatin targeting in response to replication stress. Overall, this study suggests that the phosphorylation of the BTR complex is essential to maintain a stable genome.


Subject(s)
Carrier Proteins/metabolism , Cell Cycle Proteins/metabolism , Chromosomal Instability/physiology , DNA Topoisomerases, Type I/metabolism , DNA-Binding Proteins/metabolism , M Phase Cell Cycle Checkpoints/physiology , Multiprotein Complexes/metabolism , Nuclear Proteins/metabolism , Protein Serine-Threonine Kinases/metabolism , Protein-Tyrosine Kinases/metabolism , RecQ Helicases/metabolism , Amino Acid Substitution , Carrier Proteins/genetics , Cell Cycle Proteins/genetics , DNA Topoisomerases, Type I/genetics , DNA-Binding Proteins/genetics , HEK293 Cells , HeLa Cells , Humans , Multiprotein Complexes/genetics , Mutation, Missense , Nuclear Proteins/genetics , Phosphorylation/physiology , Protein Serine-Threonine Kinases/genetics , Protein-Tyrosine Kinases/genetics , RecQ Helicases/genetics , Serine/genetics , Serine/metabolism , Spindle Apparatus/genetics , Spindle Apparatus/metabolism
2.
Cancer Res ; 73(14): 4300-10, 2013 Jul 15.
Article in English | MEDLINE | ID: mdl-23698467

ABSTRACT

Fanconi anemia (FA) is a genome instability syndrome that has been associated with both cancer predisposition and bone marrow failure. FA proteins are involved in cellular response to replication stress in which they coordinate DNA repair with DNA replication and cell-cycle progression. One regulator of the replication stress response is the ATP-dependent DNA translocase FANCM, which we have shown to be hyperphosphorylated in response to various genotoxic agents. However, the significance of this phosphorylation remained unclear. Here, we show that genotoxic stress-induced FANCM phosphorylation is ATR-dependent and that this modification is highly significant for the cellular response to replication stress. We identified serine (S1045) residue of FANCM that is phosphorylated in response to genotoxic stress and this effect is ATR-dependent. We show that S1045 is required for FANCM functions including its role in FA pathway integrity, recruiting FANCM to the site of interstrand cross links, preventing the cells from entering mitosis prematurely, and efficient activation of the CHK1 and G2-M checkpoints. Overall, our data suggest that an ATR-FANCM feedback loop is present in the FA and replication stress response pathways and that it is required for both efficient ATR/CHK1 checkpoint activation and FANCM function.


Subject(s)
DNA Helicases/genetics , DNA Helicases/metabolism , Serine/metabolism , Ataxia Telangiectasia Mutated Proteins/genetics , Ataxia Telangiectasia Mutated Proteins/metabolism , Cell Division/physiology , Cell Line , Cell Line, Tumor , Checkpoint Kinase 1 , DNA Replication , Fanconi Anemia/genetics , Fanconi Anemia/metabolism , Fanconi Anemia Complementation Group D2 Protein/genetics , Fanconi Anemia Complementation Group D2 Protein/metabolism , G2 Phase/physiology , HEK293 Cells , HeLa Cells , Humans , Mitosis/genetics , Mutation , Phosphorylation , Protein Kinases/genetics , Protein Kinases/metabolism , Serine/genetics , Signal Transduction
3.
Blood ; 119(14): 3285-94, 2012 Apr 05.
Article in English | MEDLINE | ID: mdl-22343915

ABSTRACT

Fanconi anemia (FA) nuclear core complex is a multiprotein complex required for the functional integrity of the FA-BRCA pathway regulating DNA repair. This pathway is inactivated in FA, a devastating genetic disease, which leads to hematologic defects and cancer in patients. Here we report the isolation and characterization of a novel 20-kDa FANCA-associated protein (FAAP20). We show that FAAP20 is an integral component of the FA nuclear core complex. We identify a region on FANCA that physically interacts with FAAP20, and show that FANCA regulates stability of this protein. FAAP20 contains a conserved ubiquitin-binding zinc-finger domain (UBZ), and binds K-63-linked ubiquitin chains in vitro. The FAAP20-UBZ domain is not required for interaction with FANCA, but is required for DNA-damage-induced chromatin loading of FANCA and the functional integrity of the FA pathway. These findings reveal critical roles for FAAP20 in the FA-BRCA pathway of DNA damage repair and genome maintenance.


Subject(s)
DNA Repair , Fanconi Anemia Complementation Group Proteins/metabolism , Fanconi Anemia/genetics , Fanconi Anemia/metabolism , Signal Transduction , Ubiquitin/metabolism , Cells, Cultured , Chromatin/metabolism , DNA Damage , Fanconi Anemia Complementation Group A Protein/chemistry , Fanconi Anemia Complementation Group A Protein/metabolism , Fanconi Anemia Complementation Group Proteins/chemistry , Fanconi Anemia Complementation Group Proteins/genetics , Humans , Protein Binding , Protein Interaction Domains and Motifs , Protein Stability , Zinc Fingers
4.
Mol Cell ; 37(6): 879-86, 2010 Mar 26.
Article in English | MEDLINE | ID: mdl-20347429

ABSTRACT

FANCM is a Fanconi anemia nuclear core complex protein required for the functional integrity of the FANC-BRCA pathway of DNA damage response and repair. Here we report the isolation and characterization of two histone-fold-containing FANCM-associated proteins, MHF1 and MHF2. We show that suppression of MHF1 expression results in (1) destabilization of FANCM and MHF2, (2) impairment of DNA damage-induced monoubiquitination and foci formation of FANCD2, (3) defective chromatin localization of FA nuclear core complex proteins, (4) elevated MMC-induced chromosome aberrations, and (5) sensitivity to MMC and camptothecin. We also provide biochemical evidence that MHF1 and MHF2 assemble into a heterodimer that binds DNA and enhances the DNA branch migration activity of FANCM. These findings reveal critical roles of the MHF1-MHF2 dimer in DNA damage repair and genome maintenance through FANCM.


Subject(s)
DNA Helicases/metabolism , DNA-Binding Proteins/metabolism , Fanconi Anemia/metabolism , Histones/metabolism , Protein Folding , Protein Multimerization , Cell Line, Tumor , DNA/metabolism , DNA Helicases/genetics , DNA-Binding Proteins/genetics , Fanconi Anemia/genetics , Humans , Protein Binding
5.
Blood ; 114(1): 174-80, 2009 Jul 02.
Article in English | MEDLINE | ID: mdl-19423727

ABSTRACT

FANCM is a component of the Fanconi anemia (FA) core complex and one FA patient (EUFA867) with biallelic mutations in FANCM has been described. Strikingly, we found that EUFA867 also carries biallelic mutations in FANCA. After correcting the FANCA defect in EUFA867 lymphoblasts, a "clean" FA-M cell line was generated. These cells were hypersensitive to mitomycin C, but unlike cells defective in other core complex members, FANCM(-/-) cells were proficient in monoubiquitinating FANCD2 and were sensitive to the topoisomerase inhibitor camptothecin, a feature shared only with the FA subtype D1 and N. In addition, FANCM(-/-) cells were sensitive to UV light. FANCM and a C-terminal deletion mutant rescued the cross-linker sensitivity of FANCM(-/-) cells, whereas a FANCM ATPase mutant did not. Because both mutants restored the formation of FANCD2 foci, we conclude that FANCM functions in an FA core complex-dependent and -independent manner.


Subject(s)
DNA Helicases/genetics , DNA Helicases/metabolism , Fanconi Anemia Complementation Group D2 Protein/genetics , Fanconi Anemia Complementation Group D2 Protein/metabolism , Fanconi Anemia/genetics , Fanconi Anemia/metabolism , Adenosine Triphosphatases/genetics , Adenosine Triphosphatases/metabolism , Camptothecin/pharmacology , Cell Line, Tumor , Cross-Linking Reagents/pharmacology , DNA Helicases/deficiency , Drug Resistance/genetics , Drug Resistance/physiology , Fanconi Anemia Complementation Group A Protein/genetics , Fanconi Anemia Complementation Group A Protein/metabolism , Gene Expression , Humans , Mutation , Radiation Tolerance/genetics , Radiation Tolerance/physiology , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Transfection , Ubiquitination/genetics , Ultraviolet Rays
SELECTION OF CITATIONS
SEARCH DETAIL
...